Across TCGA pan-cancer cohorts, ZNF793 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF793 data layer compared with 27 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ZNF793 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF793 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ACC, UCEC, and LIHC are the cancer types where ZNF793 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.010	0.624	<.001	34	view →
UCEC	DFS	Median	All	1.000	0.620	.008	18	view →
LIHC	OS	Median	All	0.152	0.704	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ZNF793 tumor-vs-normal RNA expression · all ZNF793 data types